ELTX Elicio Therapeutics, Inc.
$1.83▲ +7.65%
Healthcare
Other
After hours
$1.83▲ +0.00%
Oct 27, 4:42 PM ET
Volume 342.3K
Avg Volume (10D) 335.5K
Key Metrics & Fundamentals
Market Cap
$49.58M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.44 - 16.00
% vs 50 MA
-14.57%
% vs 200 MA
-73.37%
RSI-14
47.3
MACD Histogram
+0.0400
Beta (1Y vs SPY)
0.27
Free Cash Flow
-$8.17M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$10.01M
COGS
–
Operating Exp
$10.43M
Operating Income
-$10.43M
EBIT
-$10.43M
Pretax Income
-$8.22M
Net Income
-$8.22M
EPS (Diluted)
-0.43
Price & Volume History
Loading chart…
Recent News
Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine
GlobeNewswire · Oct 23, 2026 9:00 AM ET
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
GlobeNewswire · Sep 24, 2026 8:00 AM ET
B. Riley Adjusts Price Target on Elicio Therapeutics to $8 From $27, Keeps Buy Rating
MT Newswires · Sep 24, 2026 7:36 AM ET
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Aug 31, 2026 8:00 AM ET
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire · Aug 24, 2026 8:00 AM ET
Elicio Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 4:26 PM ET
Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
GlobeNewswire · Aug 13, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ELTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.